Paion - chance or hands off ?

O

old2newbie

Junior member
Messages
11
Likes
0
hello,

I am Austrian, and have 50 % of my investments in US stocks ( Tesla , Apple , Intel , IBM ).

I am always looking for new companies with a lot of potential . Have the following German company in the selection .



PAION AG ( http://www.paion.com/en/ )



This company develops a new drug , called " Remimazolam " . could be a Blockbuster



What do you think about this company , and how do you assess the chances concerning an authorization of Remimazolam in US .?

Thanks for the opinions :rolleyes:



here are some links



About Remimazolam http://www.paion.de/en/cns-7056

clinical trials in US http://www.pharmacychoice.com/News/article.cfm?Article_ID=1351535
 
Developed using molecular-level techniques, the “designer” sedative drug remimazolam provides a promising new alternative for sedation in patients undergoing colonoscopy, reports a study in the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

“Remimazolam has the attributes of a sedative drug, with success rates comparable with recent studies of other drugs,” according to the new research, led by Dr Mark T. Worthington of Johns Hopkins Hospital, Baltimore.

Remimazolam Shows Fast Onset of Sedation and Quick Recovery
The researchers evaluated the use of remimazolam, a new benzodiazepine-type sedative drug, for sedation in patients undergoing colonoscopy.

As described in a recent article in Anesthesia & Analgesia, remimazolam is an example of new anesthetic and sedative drugs being developed
with the use of molecular-level techniques. Remimazolam was specifically designed to have a faster onset, more predictable effects,
and shorter recovery time compared to currently available sedatives.


(y) good News :clap:
 
good year

Over the next few weeks of the start of Phase 3 of the EU will be announced, then it goes with the data transfer by the company ONO (Japan) further, all well "Step by Step".

Apart from the current price of the stock, it may at PAION is not running much better. Two approved Phase 3 trials in the US, an already structured sales team, with important professionals.

Did my portfolio completely filled with PAION shares, which is the share of the year (in Germany), i hope :cheesy: :cool:
 
old2newbie said:
hello,

I am Austrian, and have 50 % of my investments in US stocks ( Tesla , Apple , Intel , IBM ).

I am always looking for new companies with a lot of potential . Have the following German company in the selection .



PAION AG ( http://www.paion.com/en/ )



This company develops a new drug , called " Remimazolam " . could be a Blockbuster



What do you think about this company , and how do you assess the chances concerning an authorization of Remimazolam in US .?

Thanks for the opinions :rolleyes:



here are some links



About Remimazolam http://www.paion.de/en/cns-7056

clinical trials in US http://www.pharmacychoice.com/News/article.cfm?Article_ID=1351535
Click to expand...


mention it more on a lot of other forums ........you might get the stock moving you never know ;)

N
 
You must log in or register to reply here.
Top